Comparison |
Container Type |
Prefilled Syringe | Single Dose Vial | Single-Dose Vial | Single-Dose Vial | |
Generic Drug Name |
COVID-19 Vaccine, mRNA | COVID-19 Vaccine, mRNA | COVID-19 Vaccine, mRNA-OMNICRON XBB | COVID-19 Vaccine | COVID-19 Vaccine |
NDC Number |
00069237710 | 00069236210 | 80777010295 | 80777028792 | 59267433102 |
Product Dating |
McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 42 days | McKesson Acceptable Dating: we will ship >= 42 days | McKesson Acceptable Dating: we will ship >= 42 days | McKesson Acceptable Dating: we will ship >= 42 days |
Storage Requirements |
Requires Refrigeration | Requires Refrigeration | Keep Frozen | Keep Frozen | Requires Refrigeration |
Strength |
0.3 mg / mL | 0.1 mg / mL | 50 mcg | | 0.033 mg / mL |
UNSPSC Code |
51201653 | 51201652 | 51201652 | 51201652 | 51201652 |
User |
Indicated for People 12 Years of Age and Older | Indicated for People 12 Years of Age and Older | Indicated for People 12 Years of Age and Older | Indicated for People 6 Months to 11 Years of Age | Indicated for People 5 to 12 Years of Age |
Volume |
| | 0.5 mL | 0.25 mL | |
Application |
Coronavirus Vaccine | Coronavirus Vaccine | Coronavirus Vaccine | Coronavirus Vaccine | Coronavirus Vaccine |
Country of Origin |
Unknown | Unknown | Unknown | Unknown | Unknown |
Dosage Form |
Injection | Injection | Injection | Injection | Injection |
Type |
Intramuscular | Intramuscular | Intramuscular | Intramuscular | Intramuscular |
Features and Benefits |
- COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older
- For intramuscular injection only
|
- COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older
- For intramuscular injection only
|
- SPIKEVAX is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older
- Each 0.5 mL dose of SPIKEVAX contains 50 mcg of nucleosidemodified messenger RNA (mRNA) encoding the pre-fusion stabilized Spike glycoprotein (S) of SARS-CoV-2 virus
- For intramuscular injection only
|
|
|